| Trial arms | |||||
---|---|---|---|---|---|---|
BIAsp 30 (n = 82) | NPH/Reg Insulin (n = 82) |  | ||||
Baseline | 48Â weeks | P value | Baseline | 48Â weeks | P value | |
HbA1c (%) | 9.55 ± 1.03 | 7.15 ± 0.24 | 0.021 | 9.97 ± 1.52 | 7.62 ± 0.21 | 0.011 |
FPG (mg/dl) | 208.10 ± 4.51 | 144.33 ± 8.16 | 0.029 | 185.76 ± 12.1 | 132.00 ± 13.2 | 0.027 |
PPG (mg/dl) | 276.84 ± 9.2 | 211.51 ± 10.3 | 0.032 | 239.25 ± 12.55 | 180.88 ± 12.90 | 0.019 |
TG (mg/dl) | 183.19 ± 11.33 | 173.44 ± 12.50 | 0.247 | 191.22 ± 55.11 | 170.42 ± 40.18 | 0.631 |
Total Chol (mg/dl) | 184.41 ± 21.31 | 169.41 ± 15.13 | 0.471 | 176.33 ± 22.30 | 161.28 ± 18.34 | 0.259 |
LDL (mg/dl) | 103.72 ± 19.70 | 101.89 ± 16.42 | 0.554 | 110.39 ± 14.56 | 98.44 ± 19.45 | 0.131 |
HDL (mg/dl) | 45.34 ± 11.05 | 49.45 ± 18.65 | 0.398 | 48.55 ± 15.12 | 47.47 ± 19.35 | 0.228 |
BMI (kg/m2) | 29.37 ± 6.78 | 29.59 ± 3.62 | 0.421 | 31.78 ± 7.52 | 33.88 ± 2.89 | 0.166 |
QALY | Â | Â | Â | Â | Â | Â |
EQ-5D-3 L | 0.59 ± 0.03 | 0.73 ± 0.04 | 0.031 | 0.64 ± 0.11 | 0.66 ± 0.06 | 0.082 |
VAS | 0.61 ± 0.05 | 0.75 ± 0.06 | 0.026 | 0.69 ± 0.04 | 0.71 ± 0.08 | 0.074 |